可吸收下腔静脉滤器的临床前研究综述
该范围综述评估了可吸收下腔静脉滤器(IVCF)的设计、开发阶段、有效性及并发症,检索了MEDLINE、PubMed和Embase数据库,最终纳入8项研究(5项体内、3项体外),未发现临床试验。体内研究偏倚风险为中到高,体外研究为低到中;证据显示可吸收IVCF能有效捕获血栓并自吸收,减少标准IVCF相关并发症,但缺乏统计分析和对照组。结论认为可吸收IVCF在临床前模型中前景良好,但需进一步研究以实现理想特性,才能安全开展首次人体试验。
要点
- 可吸收IVCF在临床前模型中显示有效捕获血栓和自吸收能力。
- 可吸收IVCF可能减少标准滤器相关的并发症和取出风险。
- 现有研究缺乏统计分析和对照组,证据等级有限。
核心结论
- 可吸收IVCF在临床前模型中表现出有希望的特征和结果,但需进一步研究以实现理想特性,才能安全进行首次人体试验。
研究设计与样本
- 范围综述,检索MEDLINE、PubMed和Embase数据库并手动检索相关研究引用,由两名独立评审员筛选和提取数据,纳入8项研究(5项体内、3项体外),无临床试验。
主要发现
- 体内和体外研究均提示可吸收IVCF能有效捕获血栓并自吸收,可能减少标准IVCF相关并发症。
- 体内研究的偏倚风险为中到高,体外研究为低到中。
- 广泛缺乏统计分析和对照组以确定发现的显著性。
临床怎么用
- 目前可吸收IVCF仅用于临床前研究,尚未进入人体试验,临床不应常规使用。
局限性
- 纳入研究数量少(仅8项),且无临床试验。
- 缺乏统计分析和对照组,证据确定性有限。
- 体内研究偏倚风险为中到高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Absorbable inferior vena cava filters (IVCFs) could be more effective and safer than standard IVCFs in theory, as they will self-resorb over time, thus rendering the need for filter retrieval and the risks associated with it unnecessary. This scoping review aims to evaluate the design of current absorbable IVCFs, review the development phase of the absorbable IVCFs, assess the efficacy of the absorbable IVCFs and their complications, and discuss the limitations and areas for future research. METHODS: MEDLINE, PubMed, and Embase databases were electronically searched and citations of relevant studies manually searched. Study selection and data extraction were performed by two independent reviewers using predetermined criteria and stored on premade proforma, respectively. The risk of bias (RoB) for both in vitro and in vivo studies were performed using established RoB tools. RESULTS: Eight studies were suitable for inclusion in this scoping review; five were in vivo and three were in vitro studies. No clinical trials were found. The RoB varied from moderate to high for in vivo studies and from low to moderate for in vitro studies. Overall, there was evidence from both in vivo and in vitro studies that absorbable IVCFs were effective in clot capturing and self-resorption and could decrease complications associated with standard IVCFs. However, there was a broad lack of statistical analyses and control groups to determine the significance of these findings. CONCLUSIONS: Absorbable IVCFs have shown promising features and results in preclinical models. However, significant research needs to be further performed to achieve the ideal characteristics of an absorbable IVCF before the first human trial can be conducted safely.
引用
- Wong JKL, Tan M, Bakhshayesh P, et al. A review of preclinical absorbable inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33227458. doi:10.1016/j.jvsv.2020.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。